Kell alloimmunization in pregnancy;Allo-immunisation anti-Kell et grossesse

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 33, Issue 7, 2004, Pages 637-648

  Gariod, S ^a   Brossard, Y ^b   Poissonnier, M H ^c   Vuilliez, B ^d   Deutsch, V ^a   Jouk, P S ^a   Pons, J C ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d CHR   (France)

Author keywords

Allo immunisation; Fetal anemia; Fetal blood group; Fetal blood sampling; Hydrops fetalis; In utero transfusion; Kell

Indexed keywords

HEMOGLOBIN;

ADULT; ALLOIMMUNIZATION; AMNIOCENTESIS; BLOOD GROUP KELL SYSTEM; CASE REPORT; ECHOGRAPHY; FEMALE; FETUS ANEMIA; FETUS BLOOD SAMPLING; FETUS DISEASE; FETUS HYDROPS; FETUS MONITORING; GESTATIONAL AGE; HEMOGLOBIN DETERMINATION; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; KELL ALLOIMMUNIZATION; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; WELLBEING;

EID: 9144223679     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(04)96605-7     Document Type: Review

References (32)

1. Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986; 154: 85-90.
2. Weiner CP, Widness J. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174: 547-51.
3. Grant SR, Meer KL, Weaver JB, Gabra GS, Whittle MJ. The outcome of pregnancy in Kell alloimmunisation. Br J Obstet Gynaecol 2000; 107: 481-5.
4. Copel JA, Scioscia A, Grannum PA, Romero R, Reece EA, Hobbins JC. Percutaneous ombilical blood sampling in the management of Kell isoimmunization. Obstet Gynecol 1986; 67: 288-90.
5. Wenk RE, Goldstein P, Felix JK. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Obstet Gynecol 1985; 66: 473-76.
6. Leggat HM, Gibson JM, Barron SL, Reid MM. Anti-Kell in pregnancy. B J Obstet Gynaecol 1991; 98: 162-65.
7. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IAG. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. The New England Journal of medidine 1998; 338: 798-803.
8. Vaughan JI, Warwick R, Letsky EA, Nicolini U, Rodck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171: 247-52.
9. Schumacher B, Moise KJ. Reviews. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996; 88: 137-50.
10. Gavriil P, Jauniaux E, Lambermon M, Donner C, Avni FE, Rodesch F. Investigations périnatales de l'immunisation fœto-maternelle anti-Kell. J Obstet Biol Reprod 1989 ; 18 : 761-64.
11. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992; 79: 239-44.
12. McKenna DS, Nagaraja HN, O'Shaugnessy R. Management of pregnacies complicated by Anti-Kell isoimmunization. Obstet Gynecol 1999; 93: 667-73.
13. Rodech F, Lamberment M, Donner C, Simon Ph, Romasco F, Schwers J et al. Chorionic biopsy in management of severe Kell alloimmunization. Am J Obstet Gynecol 1987; 156: 124-5.
14. Lee S, Bennett PR, Overton T, Warwick R, Wu X, Redman CM. Prenatal dagnosis of Kell blood group genotypes: KEL 1 and KEL 2. Am J Obstet Gynecol 1996; 175: 455-9.
15. Avent ND, Martin PG. Kell typing by allele-specific PCR (ASP). Br J Haematol 1996; 93: 728-30.
16. Van der Schoot CE, Tax, GH, Rijnders RJ, De Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antifens: the edge of a watershed. Transfus Med Rev 2003; 17: 31-44.
17. Chitkara U, Wilkins I, Lynch L, Mehalek K, Berkowitz RL. The role of sonography in assessing severity of fetal anemia in Rhand Kell-isoimmunized pregnancies. Obstet Gynecol 1988; 71: 393-98.
18. Brassard Y, Chavinié J, Poissonnier MH. Traitement prénatal des incompatibilités sanguines fœto-maternelles graves. Rev Prat 1984 ; 34 : 3309-14.
19. Queenan JT, Tomai P, Ural H, King JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-Immunized pregnancies from 14 to 40 wees' gestation: a proposal for clinical management. Obstet Gynecol 1993; 168: 1370-6.
20. Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without excessive elevation of the ΔOD450 Value in amniotic fluid. Obstet Gynecol 1982; 60: 746-9.
21. Weiner, CP, Williamson RA, Wenstrom KD, Sipes SL, Grant SS, Widness JA. Management of fetal hemolytic disease by cordocentesis : prediction of fetal anemia. Am J Obstet Gynecol 1991; 165: 546-53.
22. Dukler D, Oepkes D, Seaward G, Windrim R, Ryan G. Non invasive test to predict fetal anemia: A study comparing Doppler and ultrasound parameters. Am J Obstet Gynecol 2003; 188: 1310-14.
23. Nishie EN, Brizot ML, Liao AW, Carvalho MHB, Toma O, Zugaib M. A comparison between middle cerebral artery peak systolic velocity and amniotic fluid optical density at 450 nm in the prediciton of fetal anemia. Am J Obstet Gynecol 2003; 188: 214-9.
24. Makh DS, Harman CR, Baschat AA. Is Doppler prediciton of anemia effective in the growth-restricted fetus? Ultrasound Obstet Gynecol 2003; 22: 489-92.
25. Soeters M, Arabin B, Oepkes D. Doppler sonography for predicting fetal anemia caused by massive fetomaternal hemorrhage. Ultrasound Obstet Gynecol 2003; 22: 186-9.
26. Barss VA, Benacerraf BR, Frigoletto FD, Greene MF, Penso C, Saltzman DH, Nadel A, Heffner LJ, Scherl E, Doubilet PM. Management of isoimmunized pregnancy by the use of intra-vascular techniques. Am J Obstet Gynecol 1988; 159: 932-7.
27. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant St. S, Estle L. Management of fetal hemolytic disease by cordocentesis: outcome of treatment. Am J Obtet Gynecol 1991; 165: 1302-7.
28. Poissonnier MH, Brossard Y, De Medeiros N, Vassileva J, Parnet F, Larsen M, Gosset M, Chavinié J, Duchet J. Two hundred intrauterine exchange transfusions in severe blood incompatibilities. Am J Obstet Gynecol 1989; 161: 709-13.
29. Berkowitz RL, Chitkara U, Goldberg JD, Wilkins I, Chervenak FA, Lynch L. Intrauterine intravascular transfusions for severe red blood cell isoimmimization: ultrasound-guided percutaneous approach. Am J Obstet Gynecol 1986; 155: 574-81.
30. Grannum PAT, Copel JA, Moya FR, Scioscia AL, Andres Robert J, Winn HN, Coster BC, Burdine CB, Hobbins JC. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia. Am J Obstet Gynecol 1988; 158: 914-9.
31. Brojer E, Zupanska B, Lenkiewicz B, Goralski S, Lozinska D, Przybyszewska G, Seyfried H. Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis. Pol Tyg Lek 1990; 45: 249-52.
32. Saade GR, Moise KJ, Belfort MA, Hesketh DE, Carpenter RJ. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions. Fetal Diagn Ther 1993; 8: 161-4.